Latest Breaking News On - Douglase onsi - Page 2 : comparemela.com

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients

CAMBRIDGE, Mass. , Jan. 2, 2024 /PRNewswire/ Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that enrollment.

United kingdomCynthia sirardDouglase onsiMatthew deyoungLeap therapeutics incDrug administrationLeap therapeuticsChief medical officerAnnual report

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan franciscoDouglase onsiMatthew deyoungMeredith pelsterMsc sarah cannon research instituteAmerican society of clinical oncologyPrnewswire leap therapeutics incDrug administrationLeap therapeutics incClinical oncologyGastrointestinal cancersPresentation detailsSarah cannon research institutePoster discussion

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 21, 2023 /PRNewswire/ Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E..

New yorkUnited statesUnited kingdomPiper sandlerDouglase onsiPrnewswire leap therapeutics incLeap therapeutics incChief executive officerAnnual healthcare conferencePresentation detailsAnnual healthcareLeap therapeutics

Leap Therapeutics Reports Third Quarter 2023 Financial Results

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.

United kingdomMatthew deyoungNovarock biotherapeuticsDouglase onsiDrug administrationLeap therapeutics incLeap therapeuticsChief executive officerDefiance studyDistinguish studyThird quarterFlame biosciencesAnnual reportConsolidated statementsMonths ended septemberStockholder equity

Leap Therapeutics to Participate at Upcoming Investor Conferences

Leap Therapeutics to Participate at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomDouglase onsiMatthew deyoungLeap therapeutics incPrnewswire leap therapeutics incChief executive officerPresentation detailsAnnual global investmentLeap therapeutics